'Current regimen' diaporamas de présentation

745 views • 48 slides

Nunes EP 1 , Oliveira MS 2 , Almeida MMTB 1 , Pilotto JH 2 , Ribeiro JE 2 , Faulhaber JC 1 , Norton M 3 , Zajdenverg R 1

Oral Presentation #TUAB0102. 48-Week Efficacy and Safety Results of Simplification to Single Agent Lopinavir/ritonavir (LPV/r) Regimen in Patients Suppressed Below 80 copies/mL on HAART - The KalMo Study.

360 views • 18 slides

Antiretrovirals Pricing: The Past, The Present, The Future

Antiretrovirals Pricing: The Past, The Present, The Future. Janice Lee. What did we learn from the past?. Price evolution of stavudine /lamivudine /nevirapine. >99% decrease. 76% decrease. Prices of Improved First Line Regimens At Present. Middle Income Countries.

270 views • 14 slides

TB R&R System's strong points

TB R&R System's strong points. Standardized system implemented widely Collection of follow-up information on each patient over long course of treatment Data sources succinct, cleverly designed for tabulation, cross-referencing Definitions that are clear, serve both epi and clinical purposes

151 views • 13 slides